Bluewater Bio has secured new growth investment from Verdane and Scott Capital Partners, supporting the next phase of the company’s international expansion as demand increases for advanced and sustainable wastewater treatment technologies.
The investment forms part of a new strategic partnership structure involving Verdane, Scott Capital Partners and Aquavest, aimed at scaling water and wastewater treatment technologies across established and emerging markets.
Bluewater Bio has built a strong international presence over the past decade, delivering more than 300 treatment solutions globally. The company works with municipal and industrial clients to improve wastewater performance while reducing energy use, land take and chemical inputs compared with conventional treatment approaches.
Investment aligned with rising demand for advanced treatment
Utilities and industrial operators worldwide are facing tighter discharge regulations, population growth and increasing pressure to decarbonise infrastructure. These challenges are driving interest in treatment technologies that deliver higher performance within constrained footprints and operating budgets.
Bluewater Bio’s technology portfolio is designed to address these pressures by improving treatment efficiency and enabling upgrades to existing assets without the need for extensive new civil infrastructure.
The company has also been recognised in recent years for its sustained growth and innovation in international markets, reflecting wider demand for scalable and resilient wastewater solutions.
Supporting long-term, sustainable growth
According to Bluewater Bio, the new investment will support further international expansion, strengthen delivery capability and enable continued investment in product development.
Richard Haddon, Executive Chairman and CEO of Bluewater Bio, said the partnership provides the resources needed to scale while maintaining a focus on operational quality and client outcomes.
“As we expand, our focus remains on delivering reliable, high-quality solutions that help clients improve wastewater performance and sustainability,” he said.
Building a broader wastewater technology platform
Verdane and Scott Capital Partners bring experience in supporting technology-led businesses operating in regulated infrastructure markets. The partners have indicated that Bluewater Bio will form part of a broader strategy to build an international wastewater technology platform through organic growth and targeted acquisitions.
Verdane has a track record of investing in sustainability-focused businesses across Europe, while Scott Capital Partners specialises in developing industrial and infrastructure-related platforms.
The partnership reflects growing investor confidence in the wastewater sector as a critical component of environmental protection, public health and long-term economic resilience.
Wastewater technology investment gathers pace
Investment activity across the water sector continues to accelerate as regulators and governments prioritise river health, pollution reduction and infrastructure resilience.
For wastewater technology providers, access to growth capital is increasingly seen as essential to meeting global demand while maintaining innovation, delivery capability and long-term service performance.
